About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalAustralia
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
17
As Collaborator
0
Total Enrollment
761
By Phase
PHASE2: 9PHASE3: 5PHASE1: 2
By Status
COMPLETED: 16UNKNOWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05854784Lead Sponsor
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
PHASE2Completed
6 participants
Started: Mar 28, 2023 · Completed: Dec 28, 2023
NCT04962503Lead Sponsor
A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)
PHASE2Completed
6 participants
Started: Jun 3, 2021 · Completed: Feb 4, 2022
NCT04525157Lead Sponsor
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
PHASE2Completed
21 participants
Started: Jun 6, 2014 · Completed: Jun 6, 2016
NCT01605136Lead Sponsor
Phase III Confirmatory Study in Erythropoietic Protoporphyria
PHASE3Completed
93 participants
Started: May 31, 2012 · Completed: Jul 31, 2013
NCT01382589Lead Sponsor
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
PHASE2Completed
15 participants
Started: Sep 30, 2011 · Completed: Dec 31, 2012
Locations (1)
Headquarters
Melbourne, Australia
Map
Loading map...